Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 901-950 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06760546
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
PHASE3Recruiting
39 participants
Started: Sep 23, 2025 · Completed: Sep 30, 2027
6 conditions1 sponsor8 locations
NCT07220044
Do Streaks Motivate Achievement?
NARecruiting
10,000 participants
Started: Sep 23, 2025 · Completed: Feb 23, 2026
1 condition2 sponsors1 location
NCT07011030
Diagnosis of Sarcopenia in Older Adults
NARecruiting
72 participants
Started: Sep 23, 2025 · Completed: Sep 23, 2027
1 condition1 sponsor1 location
NCT07148999
An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera
PHASE1/PHASE2Recruiting
200 participants
Started: Sep 23, 2025 · Completed: Feb 15, 2026
1 condition3 sponsors2 locations
NCT07156084
Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students
PHASE4Recruiting
300 participants
Started: Sep 23, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT07189039
Studying Access to Healthcare for Children in the Child Welfare System: the Health of Protected Children
N/ARecruiting
124 participants
Started: Sep 23, 2025 · Completed: Sep 25, 2025
1 condition2 sponsors1 location
NCT07216651
WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
N/ARecruiting
20 participants
Started: Sep 23, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05726396
A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
PHASE2Recruiting
30 participants
Started: Sep 23, 2025 · Completed: Feb 1, 2026
2 conditions1 sponsor9 locations
NCT07180407
The Post-ICU Pain Study
N/ARecruiting
800 participants
Started: Sep 23, 2025 · Completed: Jun 30, 2027
4 conditions2 sponsors4 locations
NCT07058519
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
PHASE2Recruiting
250 participants
Started: Sep 23, 2025 · Completed: Jan 24, 2029
1 condition2 sponsors1 location
NCT05642026
INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures
PHASE4Recruiting
180 participants
Started: Sep 23, 2025 · Completed: Feb 1, 2027
1 condition1 sponsor1 location
NCT06999837
[68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.
NARecruiting
40 participants
Started: Sep 23, 2025 · Completed: Sep 23, 2027
1 condition1 sponsor2 locations
NCT07211243
Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers
NARecruiting
150 participants
Started: Sep 23, 2025 · Completed: Jun 15, 2027
1 condition3 sponsors8 locations
NCT07109726
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
PHASE1/PHASE2Recruiting
205 participants
Started: Sep 23, 2025 · Completed: Feb 28, 2029
8 conditions1 sponsor4 locations
NCT07141706
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
PHASE1Recruiting
233 participants
Started: Sep 23, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor3 locations
NCT07127874
A Study of PHN-012 in Patients With Advanced Solid Tumors
PHASE1Recruiting
165 participants
Started: Sep 23, 2025 · Completed: May 31, 2028
5 conditions1 sponsor3 locations
NCT06922604
Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
PHASE1Recruiting
20 participants
Started: Sep 23, 2025 · Completed: Jan 2, 2029
2 conditions2 sponsors1 location
NCT06576687
Neurophysiology of Ankle Instability
NARecruiting
42 participants
Started: Sep 23, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06928662
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
PHASE1/PHASE2Recruiting
36 participants
Started: Sep 23, 2025 · Completed: Nov 29, 2028
13 conditions1 sponsor1 location
NCT07143890
Iron Absorption From Plant Heme Iron
NARecruiting
45 participants
Started: Sep 22, 2025 · Completed: Nov 24, 2025
2 conditions1 sponsor1 location
NCT07211607
I.V. Selonabant in Healthy Adult Subjects
PHASE1Recruiting
40 participants
Started: Sep 22, 2025 · Completed: Aug 25, 2026
1 condition2 sponsors1 location
NCT06960187
Weyera Mental Health Pilot Intervention
NARecruiting
60 participants
Started: Sep 22, 2025 · Completed: Sep 30, 2026
1 condition2 sponsors3 locations
NCT07212270
Effectiveness of Intraseptal Anesthesia for Periodontal Surgical Procedures
NARecruiting
60 participants
Started: Sep 22, 2025 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT07173543
IH, Brain Health, and T2D
NARecruiting
80 participants
Started: Sep 22, 2025 · Completed: Jun 30, 2028
2 conditions2 sponsors1 location
NCT07186283
Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers
PHASE1Recruiting
14 participants
Started: Sep 22, 2025 · Completed: Jan 3, 2026
1 condition1 sponsor2 locations
NCT06982625
Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty
NARecruiting
310 participants
Started: Sep 22, 2025 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT06964009
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
PHASE1Recruiting
30 participants
Started: Sep 22, 2025 · Completed: Dec 30, 2027
4 conditions4 sponsors2 locations
NCT07051967
Post-intensive Care Syndromes in Pregnant Patients With Respiratory Failure and COVID-19 Compared to Non-pregnant Patients With Respiratory Failure and COVID-19
N/ARecruiting
40 participants
Started: Sep 22, 2025 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT07091851
BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement
NARecruiting
50 participants
Started: Sep 22, 2025 · Completed: Apr 30, 2028
4 conditions2 sponsors1 location
NCT06865664
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
PHASE1Recruiting
50 participants
Started: Sep 22, 2025 · Completed: Apr 1, 2029
1 condition1 sponsor1 location
NCT07089784
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
PHASE1Recruiting
64 participants
Started: Sep 22, 2025 · Completed: Jan 12, 2026
1 condition1 sponsor8 locations
NCT06733584
Meeting the Needs of Young Hispanic Autistic Children
NARecruiting
200 participants
Started: Sep 22, 2025 · Completed: Jan 31, 2028
1 condition4 sponsors3 locations
NCT07140016
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
PHASE1Recruiting
40 participants
Started: Sep 22, 2025 · Completed: Dec 31, 2029
2 conditions1 sponsor2 locations
NCT07208786
Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery: a Randomized Controlled Study
NARecruiting
110 participants
Started: Sep 22, 2025 · Completed: Dec 30, 2026
5 conditions1 sponsor1 location
NCT07053423
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
PHASE4Recruiting
218 participants
Started: Sep 22, 2025 · Completed: Feb 15, 2029
1 condition2 sponsors5 locations
NCT06827990
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
NARecruiting
112 participants
Started: Sep 22, 2025 · Completed: Sep 1, 2031
1 condition1 sponsor3 locations
NCT06713603
Technology Assisted Motivational Interviewing
NARecruiting
440 participants
Started: Sep 22, 2025 · Completed: May 31, 2027
2 conditions1 sponsor2 locations
NCT07111520
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE1/PHASE2Recruiting
420 participants
Started: Sep 22, 2025 · Completed: Jan 31, 2030
1 condition2 sponsors2 locations
NCT07176728
A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.
PHASE1Recruiting
16 participants
Started: Sep 22, 2025 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT07205224
Inflammatory Response Under Spinal vs General Anesthesia in PCNL: NLR, RDW, LAR.
N/ARecruiting
90 participants
Started: Sep 22, 2025 · Completed: Oct 22, 2025
2 conditions1 sponsor1 location
NCT07168564
Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol
NARecruiting
120 participants
Started: Sep 22, 2025 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT07130734
Digital Intervention for Physical Activity
NARecruiting
50 participants
Started: Sep 22, 2025 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT07191431
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA)
NARecruiting
25 participants
Started: Sep 22, 2025 · Completed: Sep 2, 2029
1 condition1 sponsor1 location
NCT07082998
Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression
NARecruiting
120 participants
Started: Sep 22, 2025 · Completed: Jul 31, 2027
6 conditions1 sponsor1 location
NCT06869850
Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition
NARecruiting
1,600 participants
Started: Sep 22, 2025 · Completed: Dec 1, 2027
4 conditions5 sponsors10 locations
NCT06896188
9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
PHASE1Recruiting
12 participants
Started: Sep 22, 2025 · Completed: Dec 31, 2028
1 condition3 sponsors1 location
NCT07196852
Redox Status and Exercise Training-induced Adaptations
NARecruiting
60 participants
Started: Sep 22, 2025 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT07197827
A Study of YL242 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
424 participants
Started: Sep 22, 2025 · Completed: Nov 30, 2028
1 condition1 sponsor15 locations
NCT07179783
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
PHASE2Recruiting
28 participants
Started: Sep 22, 2025 · Completed: Jul 31, 2027
3 conditions2 sponsors1 location
NCT07096271
Get Better Together: Relationship Education For Military Couples
NARecruiting
1,000 participants
Started: Sep 22, 2025 · Completed: Jul 31, 2028
7 conditions2 sponsors1 location